Max Greenwald is an MD/PhD Student interested in neuropsychiatry.
He received a B.A. in Neuroscience from Middlebury College in Middlebury, VT in 2018. In 2016, Max completed a summer project studying the biogenesis of dense core vesicles (DCVs) using molecular biology approaches in Michael Ailion’s lab at the University of Washington in Seattle, WA -- Max's hometown. He spent the next two years in Glen Ernstrom’s lab at Middlebury College studying interactions and mechanisms of synaptic vesicles proteins involved in neurotransmitter loading, completing a senior thesis which earned him High Honors in Neuroscience. Following these experiences, Max became interested in human neuroscience and clinical research and was awarded a research fellowship at the National Institute of Mental Health (NIMH). After a year spent backpacking in South & Central America, he worked for two years at NIMH in the Experimental Therapeutics and Pathophysiology Branch (ETPB) clinical research lab under Carlos Zarate researching ketamine’s psychoactive and rapid-acting antidepressant effects. Max remains extremely interested in translational psychiatry research working with human subjects, with a special interest in pro-neuroplastic psychoactive therapeutics and non-ordinary states of consciousness. Outside of medicine, Max is an avid lover of traveling and the outdoors, and he tries to spend as much time as humanly possible outside of work hiking, running, eating, talking with friends, and spotting critters in the woods.
Education & Training
- Postbac Intramural Research Training Awardee (IRTA)National Institutes of Health (NIH) (2021)
- BAMiddlebury College, Neuroscience (2018)